Shagun Singh
Stock Analyst at RBC Capital
(2.60)
# 2,232
Out of 4,948 analysts
222
Total ratings
52.91%
Success rate
-0.56%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $102.75 | +11.92% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $321.27 | +8.94% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $10.82 | +131.05% | 3 | Aug 7, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $21 → $22 | $13.29 | +65.54% | 12 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $87.77 | +105.08% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $120.68 | +11.87% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $253.02 | +28.45% | 15 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $89 | $78.26 | +13.72% | 22 | Jul 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $605 → $615 | $480.26 | +28.06% | 15 | Jul 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $176.64 | +4.73% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.52 | +97.37% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $131.75 | +11.57% | 14 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $93.02 | +8.58% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $120 | $103.17 | +16.31% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $381.91 | +13.90% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $60.57 | +51.89% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $80.95 | +42.06% | 4 | Oct 25, 2024 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $102.75
Upside: +11.92%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $321.27
Upside: +8.94%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $10.82
Upside: +131.05%
Outset Medical
Aug 7, 2025
Maintains: Sector Perform
Price Target: $21 → $22
Current: $13.29
Upside: +65.54%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $87.77
Upside: +105.08%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $120.68
Upside: +11.87%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $253.02
Upside: +28.45%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $78.26
Upside: +13.72%
Intuitive Surgical
Jul 23, 2025
Maintains: Outperform
Price Target: $605 → $615
Current: $480.26
Upside: +28.06%
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $176.64
Upside: +4.73%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.52
Upside: +97.37%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $131.75
Upside: +11.57%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $93.02
Upside: +8.58%
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $103.17
Upside: +16.31%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $381.91
Upside: +13.90%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $60.57
Upside: +51.89%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $80.95
Upside: +42.06%